Abatacept
Products in Health Canada’s databases that list Abatacept as a medicinal or active ingredient, under this spelling. The same substance can be listed under another name (a salt, a common name), which has its own page.
- Drug products
- 3
- 2 authorized now
- Natural health products
- 0
- 0 active licences
- Notices of Compliance
- 16
- Products in all
- 3
Drug products
Authorized products first.
| Name | DIN | Status | Holder | Status since |
|---|---|---|---|---|
| ORENCIA (250 MG) | 02282097 | Marketed | Bristol-Myers Squibb Canada | |
| ORENCIA (125 MG) | 02402475 | Marketed | Bristol-Myers Squibb Canada | |
| ORENCIA (125 MG) | 02461919 | Cancelled Pre Market | Bristol-Myers Squibb Canada |
Notices of Compliance
Approvals of drug submissions that list it, newest first.
- ORENCIANovember 4, 2025 · NOC 36360
- ORENCIAMay 19, 2023 · NOC 30797
- ORENCIAJuly 21, 2022 · NOC 28635
- ORENCIAJune 27, 2022 · NOC 28518
- ORENCIAOctober 12, 2021 · NOC 26834
- ORENCIAApril 26, 2019 · NOC 22099
- ORENCIAMarch 15, 2018 · NOC 20625
- ORENCIAFebruary 24, 2017 · NOC 19006
- ORENCIAJune 27, 2016 · NOC 18208
- ORENCIAJune 18, 2015 · NOC 17008
- ORENCIAFebruary 21, 2013 · NOC 14146
- ORENCIAFebruary 17, 2010 · NOC 11055
- ORENCIAOctober 10, 2008 · NOC 9825
- ORENCIAJuly 11, 2008 · NOC 9673
- ORENCIAJuly 23, 2007 · NOC 8928
- ORENCIAJune 29, 2006 · NOC 8083